Uppsala University is a comprehensive research-intensive university with a strong international standing. Our ultimate goal is to conduct education and research of the highest quality and relevance to make a long-term difference in society. Our most important assets are all the individuals whose curiosity and dedication make Uppsala University one of Sweden’s most exciting workplaces. Uppsala University has over 54,000 students, more than 7,500 employees and a turnover of around SEK 8 billion.
The research group of Molecular Geriatrics is located at the Rudbeck Laboratory and is closely linked to the memory clinic at the Uppsala University Hospital. Our research is focused on protein aggregation in neurodegenerative diseases. The research is conducted in collaboration with other research groups internationally and in Sweden, as well as with various pharmaceutical companies.
Read more about our benefits and what it is like to work at Uppsala University
Alzheimer’s disease is the second most common neurodegenerative disease and is characterized by pathologically altered forms of the protein amyloid-beta in different parts of the brain. The treatment, which is aimed at increasing the levels of the signal substance acetyl choline, only relieves symptoms and is not aimed at the underlying disease process. There is therefore a great need to develop new therapies. One possibility may be to influence the formation of amyloid-beta with new gene therapeutic methods. The gene encoding this protein, APP, may in rare cases be mutated, leading to the formation of either more amyloid-beta, or an altered form of the protein. However, the vast majority of cases are sporadic, but even for these there is evidence that increased expression of APP is central in the disease process. In an ongoing project, the research team is developing a gene editing method to reduce the formation of amyloid-beta.
The researcher will carry out studies in which mutated or non-mutated forms of APP are expressed in cell and animal models of the disease. With CRISPR/Cas9, delivered by transfection or virus-mediated transduction, the gene is inactivated. Sanger- and Next Generation sequencing are used to detect effects at the DNA level. With quantitative PCRRNA levels are examined and with Western blot and immunochemical methods the presence of proteins in cell preparations and tissues are studied. Various methods for evaluating cell functions are also used. The overall goal of the study is to contribute to the development of new treatment methods for Alzheimer’s disease. The work is carried out at Uppsala University (Rudbeck Laboratory).
We welcome applications with a PhD in the biomedical field and experience in molecular biology, including work on experimental mouse models. The applicant also needs to have a good knowledge of written and spoken English.
Previous experiences in gene editing techniques, production and utilization of AAV-vectors as well as cell culture, transfection, and animal handling are meritorious.
About the employment
The employment is a temporary position, 2 years. Scope of employment 100 %. Starting date as agreed. Placement: Uppsala
For further information about the position, please contact: Professor Martin Ingelsson, email@example.com
Please submit your application by 7th of December 2022, UFV-PA 2022/4048.
Postdoc In Subcellular Resolved Spatial Transcriptomics , University of Southern Denmark, Denmark, about 24 hours ago
At the Department of Biochemistry and Molecular Biology we are looking for a highly motivated researcher for a two-year position, who will work with state-of-the-art subcellular-resolved spatial t...
Postdoctoral Position In Molecular Tools And Functional Genomics, Uppsala University, Sweden, about 3 hours ago
Published: 2023-01-13 Uppsala University is a comprehensive research-intensive university with a strong international standing. Our ultimate goal is to conduct education and research of the highe...
Fachbereich Biologie, Chemie, Pharmazie Institut Für Biologie Biochemistry Of Plant Microbe Interactions Research Group Wiermer Research Assistant (Praedoc) (M/F/D) With 50 % Part Time Job Limited To 4 Years Entgeltgruppe 13 Tv L Fu Reference Code: 21233400 01 23 Bewerbungsende: 13.02.2023, Free University of Berlin, Germany, about 2 hours ago
Research efforts in the department Biochemistry of Plant-Microbe Interactions are directed towards understanding how plants defend themselves against infection by pathogenic microbes such as bacte...
Postdoc In Stem Cell Biology At Department Of Drug Design And Pharmacology, University of Copenhagen, Denmark, about 24 hours ago
Faculty of Health and Medical Sciences University of Copenhagen We are looking for a highly motivated and dynamic researcher for a 2-year post-doctoral position in Stem Cell Biology to start in th...
Post Doc In Quantitative Cell Biology/Biochemistry/Bioengineering, University of Groningen, Netherlands, about 13 hours ago
Founded in 1614, the University of Groningen University of Groningen ( https://www.rug.nl ) enjoys an international reputation as a dynamic and innovative centre of higher education offering high-...
Research Assistant To Karolinska Institutet, Karolinska Institute, Sweden, 3 days ago
Do you want to contribute to improving human health? The laboratory of Professor Thomas Helleday provides an excellent translational and scientific environment. The multidisciplinary research grou...